Edition:
United States

Celldex Therapeutics Inc (CLDX.A)

CLDX.A on American Stock Exchange

2.35USD
10 Jul 2019
Change (% chg)

-- (--)
Prev Close
$2.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
348
52-wk High
$9.00
52-wk Low
$2.41

About

Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (also referred to as rindopepimut and CDX-110) is a therapeutic vaccine, which is meant for the... (more)

Overall

Beta: 3.61
Market Cap(Mil.): $32.49
Shares Outstanding(Mil.): 13.77
Dividend: --
Yield (%): --

Financials

  CLDX.A Industry Sector
P/E (TTM): -- 97.98 34.52
EPS (TTM): -4.54 -- --
ROI: -33.20 7.77 12.69
ROE: -40.76 8.27 17.17

Earnings vs. Estimates